Pfizer has entered into a global collaboration and license agreement with YaoPharma for the development, manufacturing and commercialization of YP05002, a small-molecule GLP-1 receptor agonist currently in phase 1 development for chronic weight management. YaoPharma, a subsidiary of Shanghai Fosun…

The FDA has launched a safety review of approved respiratory syncytial virus therapies for infants, including Beyfortus from Sanofi and AstraZeneca and Enflonsia from Merck, Reuters reported Dec. 9. Senior executives from the three companies were informed last week that…

Nearly 4 million Medicare-eligible Americans face heightened risk of disrupted medication access as restructuring efforts by the U.S. Postal Service slow mail delivery in rural and underserved communities reliant on mail-order prescriptions, according to a Dec. 4 analysis from The…

The FDA has recalled multiple lots of a blood pressure medication sold under the brand name Ziac, according to a Dec. 6 report from USA Today.  The medication — bisoprolol fumarate and hydrochlorothiazide tablets — is manufactured by Glenmark Pharmaceuticals…

Here are 23 recent drug shortages and discontinuations, according to the FDA’s drug supply databases: Discontinued In shortage

Mirum Pharmaceuticals has entered a definitive agreement to acquire Bluejay Therapeutics — a deal that, if finalized, would add brelovitug, a phase 3-stage monoclonal antibody for chronic hepatitis delta virus, to its rare liver disease therapy pipeline. The $620 million…

President Donald Trump has directed HHS and the CDC to conduct a review of childhood vaccine recommendations abroad, aiming to align U.S. guidance with best practices from “peer, developed countries.” The directive came via a memorandum the president signed Dec.…

Cost Plus Drugs co-founder Mark Cuban and Humana CEO Jim Rechtin hinted at their companies are working together, Forbes reported Dec. 4. “We’re talking to CenterWell,” Mr. Cuban said during the Forbes Healthcare Summit. “I would say we are treating…

Becker’s asked pharmacy leaders across the U.S. one question: What innovation are you looking to scale for 2026 — and why? Their answers reveal a sector doubling down on automation, access and operational resilience. Access at the point of care…

The CDC’s Advisory Committee on Immunization Practices voted 8-3 in favor of limiting national recommendations on which infants should receive a hepatitis B vaccine at birth.  The panel voted Dec. 5 to exclusively recommend the first hepatitis B shot to…